Organon & Co. (OGN) Insider Trading

Last 12 months

Insiders bought $855k and sold $553k on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. SVP and Corporate Controller Lynette Holzbaur sold $353k on May 6, 100% of their stake, outside a plan.

Net open-market

+$301k

2 buys · 2 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

2 / 2

executives and directors

Last open-market buy

May 2026

May 6, 2026

Get an email when OGN's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 5	Juliana Papa Drinane Head of Mfg & Supply	SoldNo plan	14,761	$13.57	$200k	44%	Form 4
May 6	Lynette Holzbaur SVP and Corporate Controller	Bought	26,448	$13.35	$353k	100%	Form 4
May 6	Lynette Holzbaur SVP and Corporate Controller	SoldNo plan	26,448	$13.35	$353k	100%	Form 4
Nov 12, 2025	Carrie Smith Cox Executive Chair	Bought	65,400	$7.67	$502k	525%	Form 4
May 14, 2025	Carrie Smith Cox Director	Bought	12,469	$8.07	$101k	New	Form 4
May 7, 2025	Aaron Falcione Chief Human Resources Officer	Bought	5,500	$8.77	$48k	9.6%	Form 4
May 6, 2025	Kirke Weaver Gen. Counsel & Corp. Secy.	Bought	8,045	$9.21	$74k	18%	Form 4
May 6, 2025	Daniel Karp Executive VP, Corp. Dev.	Bought	3,500	$8.24	$29k	8.1%	Form 4
May 5, 2025	Matthew M Walsh Chief Financial Officer	Bought	11,400	$8.82	$101k	8.6%	Form 4
May 5, 2025	Kevin Ali Chief Executive Officer	Bought	34,000	$8.81	$300k	14%	Form 4

Aug 5No plan
Juliana Papa Drinane
Head of Mfg & Supply · sold 14,761 at $13.57
$200k
44% of stake
May 6
Lynette Holzbaur
SVP and Corporate Controller · bought 26,448 at $13.35
$353k
100% of stake
May 6No plan
Lynette Holzbaur
SVP and Corporate Controller · sold 26,448 at $13.35
$353k
100% of stake
Nov 12, 2025
Carrie Smith Cox
Executive Chair · bought 65,400 at $7.67
$502k
525% of stake
May 14, 2025
Carrie Smith Cox
Director · bought 12,469 at $8.07
$101k
New position
May 7, 2025
Aaron Falcione
Chief Human Resources Officer · bought 5,500 at $8.77
$48k
9.6% of stake
May 6, 2025
Kirke Weaver
Gen. Counsel & Corp. Secy. · bought 8,045 at $9.21
$74k
18% of stake
May 6, 2025
Daniel Karp
Executive VP, Corp. Dev. · bought 3,500 at $8.24
$29k
8.1% of stake
May 5, 2025
Matthew M Walsh
Chief Financial Officer · bought 11,400 at $8.82
$101k
8.6% of stake
May 5, 2025
Kevin Ali
Chief Executive Officer · bought 34,000 at $8.81
$300k
14% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch OGN, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Pharmaceutical Preparations

ONCBeOne Medicines Ltd.

ELANElanco Animal Health Incorporated

JAZZJazz Pharmaceuticals plc

PRGOPerrigo Company plc

ALNYAlnylam Pharmaceuticals Inc

BMRNBiomarin Pharmaceutical Inc.

UTHRUnited Therapeutics Corporation

AMRXAmneal Pharmaceuticals Inc.

Spot a number that looks wrong? Check it in OGN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing OGN

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.